OCA and NTP treatment significantly reduced hepatic steatosis and alanine transaminase and aspartate aminotransferase, compared to the vehicle control, in HFD/HFGW-fed mice (Figures 1D–F). The gene discussed is GPT; the disease is fatty liver disease.